The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 5 , Pages 970-976 , November 2010

General thoracic surgery is safe in patients taking clopidogrel (Plavix)

Read at the 90th Annual Meeting of The American Association for Thoracic Surgery, Toronto, Ontario, Canada, May 1–5, 2010.

  • Robert James Cerfolio, MD, FACS, FCCP

      Affiliations

    • Division of Cardiothoracic Surgery, Section of Thoracic Surgery, University of Alabama at Birmingham, Birmingham, Ala
    • Corresponding Author InformationAddress for reprints: Robert J. Cerfolio, MD, Professor of Surgery, Chief of Thoracic Surgery, Division of Cardiothoracic Surgery, University of Alabama at Birmingham, 703 19th St S, ZRB 739, Birmingham, AL 35294.
  • ,
  • Douglas J. Minnich, MD

      Affiliations

    • Division of Cardiothoracic Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Ala
  • ,
  • Ayesha S. Bryant, MSPH, MD

      Affiliations

    • Division of Cardiothoracic Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Ala

Received 3 May 2010 ,Revised 12 July 2010 ,Accepted 19 July 2010.

References 

  1. Weitz HI, Hirsh J, Samama MM. New antithrombotic drugs. Chest. 2008;133:234S–256S
  2. Iakovou I, Schmidt T, Bonizzoni E, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–2130
  3. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803–2809
  4. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297:159–168
  5. Newsome LT, Weller RS, Gerancher JC, Kutcher MA, Royster RL. Coronary artery stents. II: Perioperative considerations and management. Anesth Analg. 2008;107:570–590
  6. Grines CL, Bonow RO, Casey DE, Gardner TJ, Lockhart PB, Moliterno DJ, et al. American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007;115:813–818
  7. Kim DH, Daskalakis C, Silvestry SC, Sheth MP, Lee AN, Adams S, et al. Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2009;138:1377–1384
  8. Chen L, Bracey AW, Radovancevic R, Cooper JR, Collard CD, Vaughn WK, et al. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2004;128:425–431
  9. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969
  10. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol. 1999;150:327–333
  11. US Food and Drug Administration . Circulatory System Devices Panel. Available at. www.fda.gov/ohrms/dockets/ac/cdrh06.html#circulatoryAccessed March 19, 2007
  12. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000;35:1288–1294
  13. Sharma AK, Ajani AE, Jamwi SM, Maniar P, Lakhani SV, Waksman R, et al. Major noncardiac surgery following coronary stenting: when is it safe to operate?. Catheter Cardiovasc Interv. 2004;63:141–145
  14. Cerfolio RJ, Bryant AS. Results of a prospective algorithm to remove chest tubes after pulmonary resection with high output. J Thorac Cardiovasc Surg. 2008;135:269–273

 Disclosures: Robert J. Cerfolio: E plus health care, speaker; Ethicon, speaker/consultant; Neomend, consultant; Millicore, speaker/consultant; Medela, speaker/consultant; Closure/J&J, consultant; OSI Pharm, speaker; Atrium, consultant/speaker; Oncotech, speaker; Covidien, speaker; Precision, consultant/speaker. Douglas J. Minnich and Ayesha S. Bryant have no financial disclosures to report.

PII: S0022-5223(10)00777-4

doi: 10.1016/j.jtcvs.2010.07.051

The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 5 , Pages 970-976 , November 2010